PURPOSE: To investigate the association between a validated, gene-expression-based, aggressiveness assay, Oncotype Dx RS, and morphological and texture-based image features extracted from magnetic resonance imaging (MRI). MATERIALS AND METHODS: This retrospective study received Internal Review Board approval and need for informed consent was waived. Between 2006-2012, we identified breast cancer patients with: 1) ER+, PR+, and HER2- invasive ductal carcinoma (IDC); 2) preoperative breast MRI; and 3) Oncotype Dx RS test results. Extracted features included morphological, histogram, and gray-scale correlation matrix (GLCM)-based texture features computed from tumors contoured on pre- and three postcontrast MR images. Linear regression analysis was performed to investigate the association between Oncotype Dx RS and different clinical, pathologic, and imaging features. P < 0.05 was considered statistically significant. RESULTS: Ninety-five patients with IDC were included with a median Oncotype Dx RS of 16 (range: 0-45). Using stepwise multiple linear regression modeling, two MR-derived image features, kurtosis in the first and third postcontrast images and histologic nuclear grade, were found to be significantly correlated with the Oncotype Dx RS with P = 0.0056, 0.0005, and 0.0105, respectively. The overall model resulted in statistically significant correlation with Oncotype Dx RS with an R-squared value of 0.23 (adjusted R-squared = 0.20; P = 0.0002) and a Spearman's rank correlation coefficient of 0.49 (P < 0.0001). CONCLUSION: A model for IDC using imaging and pathology information correlates with Oncotype Dx RS scores, suggesting that image-based features could also predict the likelihood of recurrence and magnitude of chemotherapy benefit.
PURPOSE: To investigate the association between a validated, gene-expression-based, aggressiveness assay, Oncotype Dx RS, and morphological and texture-based image features extracted from magnetic resonance imaging (MRI). MATERIALS AND METHODS: This retrospective study received Internal Review Board approval and need for informed consent was waived. Between 2006-2012, we identified breast cancerpatients with: 1) ER+, PR+, and HER2- invasive ductal carcinoma (IDC); 2) preoperative breast MRI; and 3) Oncotype Dx RS test results. Extracted features included morphological, histogram, and gray-scale correlation matrix (GLCM)-based texture features computed from tumors contoured on pre- and three postcontrast MR images. Linear regression analysis was performed to investigate the association between Oncotype Dx RS and different clinical, pathologic, and imaging features. P < 0.05 was considered statistically significant. RESULTS: Ninety-five patients with IDC were included with a median Oncotype Dx RS of 16 (range: 0-45). Using stepwise multiple linear regression modeling, two MR-derived image features, kurtosis in the first and third postcontrast images and histologic nuclear grade, were found to be significantly correlated with the Oncotype Dx RS with P = 0.0056, 0.0005, and 0.0105, respectively. The overall model resulted in statistically significant correlation with Oncotype Dx RS with an R-squared value of 0.23 (adjusted R-squared = 0.20; P = 0.0002) and a Spearman's rank correlation coefficient of 0.49 (P < 0.0001). CONCLUSION: A model for IDC using imaging and pathology information correlates with Oncotype Dx RS scores, suggesting that image-based features could also predict the likelihood of recurrence and magnitude of chemotherapy benefit.
Authors: Gong Tang; Steven Shak; Soonmyung Paik; Stewart J Anderson; Joseph P Costantino; Charles E Geyer; Eleftherios P Mamounas; D Lawrence Wickerham; Norman Wolmark Journal: Breast Cancer Res Treat Date: 2011-01-11 Impact factor: 4.872
Authors: Laurel A Habel; Steven Shak; Marlena K Jacobs; Angela Capra; Claire Alexander; Mylan Pho; Joffre Baker; Michael Walker; Drew Watson; James Hackett; Noelle T Blick; Deborah Greenberg; Louis Fehrenbacher; Bryan Langholz; Charles P Quesenberry Journal: Breast Cancer Res Date: 2006-05-31 Impact factor: 6.466
Authors: Elizabeth J Sutton; Brittany Z Dashevsky; Jung Hun Oh; Harini Veeraraghavan; Aditya P Apte; Sunitha B Thakur; Elizabeth A Morris; Joseph O Deasy Journal: J Magn Reson Imaging Date: 2016-01-12 Impact factor: 4.813
Authors: Jia Wu; Yi Cui; Xiaoli Sun; Guohong Cao; Bailiang Li; Debra M Ikeda; Allison W Kurian; Ruijiang Li Journal: Clin Cancer Res Date: 2017-01-10 Impact factor: 12.531
Authors: Nita Amornsiripanitch; Vicky T Nguyen; Habib Rahbar; Daniel S Hippe; Vijayakrishna K Gadi; Mara H Rendi; Savannah C Partridge Journal: J Magn Reson Imaging Date: 2017-11-27 Impact factor: 4.813
Authors: Habib Rahbar; Elizabeth S McDonald; Janie M Lee; Savannah C Partridge; Christoph I Lee Journal: Acad Radiol Date: 2016-03-23 Impact factor: 3.173
Authors: C Chennubhotla; L P Clarke; A Fedorov; D Foran; G Harris; E Helton; R Nordstrom; F Prior; D Rubin; J H Saltz; E Shalley; A Sharma Journal: Yearb Med Inform Date: 2017-09-11